Shares of Oculis Holding AG (NASDAQ:OCS – Get Free Report) have earned an average rating of “Buy” from the nine brokerages that are currently covering the company, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have updated their coverage on the stock […]
Related Keywords
United States , America , Stifel Nicolaus , Nasdaq , Wolverine Asset Management , Barclays Plc , Nan Fung Group Holdings Ltd , Oculis Holding , Oculis Company Profile , Get Free Report , Chardan Capital , Fung Group Holdings Ltd , Get Free , Oculis Daily , Oculis , Nasdaq Ocs , Docs , Medical , Ratings , Consensus ,
vimarsana.com © 2020. All Rights Reserved.